Active deployment began Nov ’25, so 8 of 9 checks are under 10 months old. This is a record of access and early momentum on $25–50k checks, not realized returns. Fund II scales the check ~10x to turn the same access into real ownership.
| Company | Sector | Founder | Check | Total raised | How we got in | Co-investors | Progress since our check |
|---|---|---|---|---|---|---|---|
| HydraDAOSeed | Organ replacement / immortality | Kai Micah Mills↗ Thiel Fellow, 3x exited |
$50k | $4.1M | Bought secondaries after token dip; already knew founder | Moonrock Capital | Spinal cord fusion in live rats (subjects walked again) |
| ZaviaBioPre-seed | Weed-resistant crops / food security | Paz Alvarez↗ Obsessed storyteller + strong CSO |
$25k | $0.46M | First US institutional check into the company | GRIDx | Target protein −50% in greenhouse trial; seed in ~6 mos |
| Lume HealthPre-seed | Continuous cortisol monitor | Vicki Powell↗ ex-Apple wearables + Oxford |
$50k | $2.27M | Advised founder 6 mos before the round to earn allocation | Oxford Seed Fund, Supermoon, Disrupt VC | 1k pre-orders; <6% variability prototype |
| DognosisSeed | Dog BCIs for cancer screening | Akash Kulgod↗ Berkeley + IDF K9 unit |
$25k | $6.2M | In just before the round turned hot / oversubscribed | BoostVC, Caffeinated, Draper, 1517, Accel India | Marked up to $25M (from $15M); 90%+ accuracy, 25 pilot hospitals |
| Origin GenomicsSeed | Germline DNA editing in embryos | Cathy Tie↗ Thiel Fellow, dropout, PR machine |
$50k | (unannounced) | First check in the seed; already knew founder | (unannounced) | Recruited a world CRISPR pioneer; first-ever IRB approval for embryo editing |
| Kangaroo BioPre-seed | Artificial wombs | Landice Gao↗ YC + Stanford PhD |
$50k | $4.8M | Re-opened a closed pre-seed (after I introed founder to Nucleus CEO) | Draper, Alumni Ventures, Halogen VC | Endometrium alive 4 wks ex-body; monkey trials next |
| ElectrokarePre-seed | AI biomarker prediction | Mitchell Leshchiner↗ 21, first company at 12 |
$25k | $2M | Into a closing round last-minute on a warm intro & value add | a16z, Techstars, Mayo Clinic | $2M ARR + Mayo Clinic partnership, all in <15 mos |
| HerasightSeed | Embryo selection | Michael Christensen↗ Math dropout + quant |
$50k | $10M | In ahead of their first real institutional round; warm intro | Tim Draper, Long Game VC | $5M+ ARR on word-of-mouth; priced round in ~6 mos |
| Kadence BioSeries A | Sexual enhancement | John Boghossian↗ Compass & Atai co-founder, MIT |
$25k | $23M | Warm intro into an oversubscribed round | Apeiron | Phase 2a clinical trial in progress |
| Total | $350k | $52.83M | Sum of checks · total round volume accessed | ||||